Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP in anal fistula repair
NCT02678936Phase 4Withdrawn
- Sponsor
- University Hospital Basel
- Start
- Nov 2015
- Primary completion
- Nov 2015
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of platelet-rich plasma in anal fistula (2 arms), sponsored by University Hospital Basel. Primary endpoint: Healing rate at 2 years. Planned start Nov 2015; status: withdrawn.
02
Drugs
platelet-rich plasma
03
Conditions
anal fistula
Beyond the preview
Go deeper on NCT02678936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02678936.